Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Gt Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14Obesity, fitness, & wellness week, 2024-07, p.1739NewsRX LLCTexto completo disponível |
|
2 |
Material Type: Artigo
|
Gt Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Jun. 17, 2024)Obesity, fitness, & wellness week, 2024-07, p.1739NewsRX LLCTexto completo disponível |
|
3 |
Material Type: Artigo
|
Cue Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (May 24, 2024)Obesity, fitness, & wellness week, 2024-06, p.1511NewsRX LLCTexto completo disponível |
|
4 |
Material Type: Artigo
|
Cue Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14Obesity, fitness, & wellness week, 2024-06, p.1511NewsRX LLCTexto completo disponível |
|
5 |
Material Type: Artigo
|
Aeon Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (May 14, 2024)Obesity, fitness, & wellness week, 2024-06, p.1709NewsRX LLCTexto completo disponível |
|
6 |
Material Type: Artigo
|
Aeon Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14Obesity, fitness, & wellness week, 2024-06, p.1709NewsRX LLCTexto completo disponível |
|
7 |
Material Type: Artigo
|
Cue Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Apr. 26, 2024)Obesity, fitness, & wellness week, 2024-05, p.1551NewsRX LLCTexto completo disponível |
|
8 |
Material Type: Artigo
|
Gt Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14Obesity, fitness, & wellness week, 2024-05, p.1624NewsRX LLCTexto completo disponível |
|
9 |
Material Type: Artigo
|
Gt Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Apr. 29, 2024)Obesity, fitness, & wellness week, 2024-05, p.1624NewsRX LLCTexto completo disponível |
|
10 |
Material Type: Artigo
|
Cue Biopharma, Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14Obesity, fitness, & wellness week, 2024-05, p.1551NewsRX LLCTexto completo disponível |